» Articles » PMID: 28161498

Survival Impact of Waiting Time for Radical Radiotherapy in Nasopharyngeal Carcinoma: A Large Institution-based Cohort Study from an Endemic Area

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2017 Feb 6
PMID 28161498
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whether the waiting time for radical radiotherapy (WRT) detrimentally impacts nasopharyngeal carcinoma (NPC) prognosis is unclear. We estimated the influence of WRT on overall survival (OS) and disease-specific survival (DSS) of NPC.

Patients And Methods: Patients were identified from prospectively maintained database. WRT was calculated from histological diagnosis to initiation of radiotherapy (RT). Survival analysis was estimated using Weibull parametric model and propensity score analysis (PSA). Recursive partitioning analysis (RPA) identified optimal WRT threshold via conditional inference trees to estimate the greatest survival differences based on randomly selected training and validation sets, and this process was repeated 1000 times to ensure threshold robustness. Sensitivity analysis estimated effects of potential unmeasured confounders.

Results: A total of 9896 patients were included. In multivariate analysis, WRT of 31-60°d, of 61-90°d and of greater than 90°d independently increased mortality risk compared to less than 30°d. Upon RPA, ranges of 30-35°d with the peak of 30°d were confirmed with 89% of simulations validating optimal thresholds. In threshold-based groups, adjusted hazard ratios (HRs) for WRT of greater than 30°d by both Weibull model and PSA were significantly higher than for WRT of less than 30°d [OS: HR = 1.13, 95% confidence interval (CI) 1.04-1.23, P = 0.003; DSS: HR = 1.15, 95% CI 1.05-1.26, P = 0.002]. Sensitivity analysis revealed robustness of results.

Conclusions: WRT independently affects survival. Increasing WRT beyond 30°d was most consistently detrimental to survival. WRT of NPC should be as short as reasonably achievable (ASARA).

Citing Articles

Real-time artificial intelligence-assisted detection and segmentation of nasopharyngeal carcinoma using multimodal endoscopic data: a multi-center, prospective study.

He R, Jie P, Hou W, Long Y, Zhou G, Wu S EClinicalMedicine. 2025; 81:103120.

PMID: 40026832 PMC: 11871492. DOI: 10.1016/j.eclinm.2025.103120.


A deep learning based smartphone application for early detection of nasopharyngeal carcinoma using endoscopic images.

Yue Y, Zeng X, Lin H, Xu J, Zhang F, Zhou K NPJ Digit Med. 2024; 7(1):384.

PMID: 39738998 PMC: 11685909. DOI: 10.1038/s41746-024-01403-2.


Selection of induction chemotherapy cycles for stage N3 nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA.

Weng Y, Cai S, Li C, Xu Y, Pan Y, Huang Z Sci Rep. 2024; 14(1):24484.

PMID: 39424840 PMC: 11489564. DOI: 10.1038/s41598-024-75396-z.


Application of Artificial Intelligence to the Diagnosis and Therapy of Nasopharyngeal Carcinoma.

Yang X, Wu J, Chen X J Clin Med. 2023; 12(9).

PMID: 37176518 PMC: 10178972. DOI: 10.3390/jcm12093077.


Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

Li Y, Bi J, Pi G, He H, Li Y, Zheng D Cancer Med. 2023; 12(8):9449-9457.

PMID: 36872566 PMC: 10166969. DOI: 10.1002/cam4.5707.